Base2 Genomics LLC

Biotech · Private

Cloud-based platform for whole genome sequencing data processing, variant detection, and analysis

Grants
$748K
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase I · An innovative WGS platform for discovery, annotation, and interpretation of all forms of human genetic variation.$299,281
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · An innovative WGS platform for discovery, annotation, and interpretation of all forms of human genetic variation.$373,781
Federal grantDepartment of Health and Human Services · Phase I · An innovative WGS platform for discovery, annotation, and interpretation of all forms of human genetic variation.$74,500
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1954Caring Brands, Inc.—$1.8M
1955KIBIO INC.——
1956SAROS THERAPEUTICS INC——
1957Base2 Genomics LLC——
1958PAXVAX, INC.—$58M
1959Synbiotic Health, Inc.—$6.0M
1960CelLink Corp—$25M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.